Arrowhead Pharmaceuticals Inc.
NASDAQ: ARWR
$32.58
Closing price February 8, 2023
Wednesday's top analyst upgrades and downgrades included APA, Delta Air Lines, Generac, Lululemon Athletica, Microchip Technology, Paccar, Philip Morris International, Pinduoduo, Shopify,...
2 months ago
Last Updated: 2 months ago
Thursday's top analyst upgrades and downgrades included Alcon, Array Technologies, AZEK, Boeing, Capital One Financial, Coinbase Global, Corning, Electronic Arts, Harley-Davidson, ON Semiconductor,...
8 months ago
Last Updated: 8 months ago
24/7 Wall St. looks at some big analyst upgrades and downgrades that we have seen so far on Friday, including American Water Works, Carnival, Duke Energy, Okta and Zscaler.
1 year ago
The Friday afternoon analyst calls were focused on Biogen, Fortinet, Pinterest, Snap and more.
2 years ago
Last Updated: 1 year ago
Arrowhead Pharmaceuticals has announced positive interim 24-week liver biopsy results in four subjects from its midstage study of ARO-AAT. Shares rallied on the news early Wednesday.
2 years ago
Last Updated: 1 year ago
Get Our Free Investment Newsletter